Emibetuzumab (Anti-HGFR / c-Met)
Emibetuzumab (Anti-HGFR / c-Met) is a humanized bivalent MET antibody targeting both HGF-dependent and HGF-independent MET pathway activation and tumor growth. It can be used in study of cancer. MW :144.56 KD.
Supplier | Selleck Chemicals |
---|---|
Product # | A2662 |
Sku # | A2662-1mg*25 |
Pricing | 1mg*25, $2370.00 |